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Abstract
The rs12979860 single nucleotide polymorphism located on chromosome 19q13.13 near the interferon L3 gene (formerly
and commonly known as interleukin 28B gene) has been associated in adults with both spontaneous and treatment
induced clearance of hepatitis C virus. Although the exact mechanism of these associations remains unclear, it suggests that
variation in genes involved in the immune response against the virus favours viral clearance. Limited and preliminary data
are available on this issue in children. The aim of the present study was to evaluate, in a representative cohort of children
with perinatal infection, the potential association between rs12979860 single nucleotide polymorphism and the outcome of
hepatitis C virus infection. Alleles and genotypes frequencies were evaluated in 30 children who spontaneously cleared the
virus and in 147 children with persistent infection and were compared with a population sample of ethnically matched
controls with unknown hepatitis C status obtained using the 1000 Genomes Project data. The C allele and the C/C genotype
showed greater frequencies in the clearance group (76.7% and 56.7%, respectively) when compared with both children with
viral persistence (C allele 56.5%, p = 0.004; C/C genotype 32.7%, p = 0.02) and with the ethnically matched individuals (C
allele 59.7%, p = 0.02; C/C genotype 34.7%, p = 0.03). Children with the C/C genotype were 2 times more likely to clear
hepatitis C virus relative to children with the C/T and T/T genotypes combined (odds ratio: 2.7; 90% confidence intervals:
1.3–5.8). The present study provides the evidence that the rs12979860 single nucleotide polymorphism influences the
natural history of hepatitis C virus in children.
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Introduction
The rs12979860 single nucleotide polymorphism (SNP) on
chromosome 19q13.13 near the IFNL3 gene (formerly and
commonly known as IL28B) has been associated in adults with
both spontaneous and treatment induced clearance of hepatitis C
virus (HCV) [1,2]. Three interferon (IFN)-l genes, IFNL1, IFNL2
(formerly IL29 and IL28A, respectively) and IFNL3 reside
downstream of the rs12979860 SNP [3]. IFN-l genes encode
the type III IFNs. Type III IFNs (IFN-ls) like type I IFNs (IFN-a
and IFN-b) induce antiviral activity and suppress HCV replication
in vitro and in vivo through activation of the JAK-STAT pathway
which leads to induction of several IFN stimulated genes which are
responsible for antiviral activity [3]. Although the exact molecular
phenotype of the genetic association between rs12979860 SNP of
the IFNL3 gene and clearance of HCV remains unclear, it is
evident that variation in genes involved in the immune response
against the virus favours viral clearance [3].
There is evidence that the frequency of the C allele of the
rs12979860 SNP varies markedly across ethnic groups [1]. The C
allele is less frequent among individuals of African ancestry relative
to those of European ancestry and East Asians [1]. It is well known
that that the probability of being cured by the combined treatment
with pegylated IFN-a and ribavirin increases accordingly [4–6]. It
has been estimated that approximately half of the difference in
sustained virological response rates to combined treatment with
pegylated IFN-a and ribavirin among these different ethnic groups
can be accounted for by the difference in the frequency of the C
allele [2].
Most of the studies published on the association between
rs12979860 SNP of the IFNL3 gene and spontaneous clearance of
HCV have been performed in adults. Only two studies on small
cohorts of children are available so far on the topic [7,8]. The
natural history of hepatitis C in children is different when
compared to adults [9,10]. Liver disease severity tends to be milder
in children than in adults. This is thought to be the consequence of
the different interplay between the virus and the immune system of
the child and it is particularly true when the infection is acquired
perinatally from the mother in the context of the high level of
immune tolerance of the developing immune system of the
newborn [11].
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To confirm the potential effect of rs12979860 SNP of the IFNL3
gene on the outcome of HCV infection in terms of spontaneous
clearance and chronic infection in children, this variant was
genotyped in an HCV cohort comprised of mono-ethnic children
who spontaneously cleared the virus or had persistent infection.
Allele and genotype frequencies in this cohort were compared with
a population sample of ethnically matched controls with unknown
hepatitis C status obtained using the 1000 Genomes Project data
[12].
Materials and Methods
Study design
This is a cross-sectional study. All the children, born to an
HCV-infected mother and older than 30 months evaluated
between January 2011 to December 2012 during routine follow-
up visits for perinatal HCV infection were recruited. Only children
whose parents or guardians provided written informed consent
were enrolled and genotyped for the SNP rs 12979860.
Retrospective data to define the source and the outcome of the
infection were collected at the time of the enrolment. All the
children enrolled were negative for hepatitis B surface antigen and
for antibodies against human immunodeficiency virus. The ethnic
origin of the children enrolled was self-reported by the parents or
guardians. The study received the approval of the ethical
committee of the Meyer Children’s University Hospital of
Florence.
Definitions
Mother-to-child transmission of HCV was defined as transmis-
sion occurring during pregnancy or in the perinatal period from
the HCV-infected mother to the foetus or to the child [13].
Maternal infection was confirmed basing on HCV antibodies
testing in the last trimester before pregnancy or during pregnancy.
Children were considered perinatally infected if HCV ribonucleic
acid was detected in at least two serum samples at least three
months apart during the first year of life, and/or when testing of
antibodies against HCV was positive after 18 months of age [14].
Spontaneous clearance of HCV in children with perinatal
infection is a well known phenomenon described in about 20%
of the children with perinatal infection and occurring in the first 30
months of life [15]. Spontaneous clearance was therefore defined
in children older than 30 months of age when polymerase chain
reaction for HCV ribonucleic acid was negative and HCV
antibodies were positive in at least three blood samples taken 6
months apart [9,15,16]. In the same age group positive
polymerase chain reactions for HCV ribonucleic acid and HCV
antibodies defined chronic hepatitis C [9,15]. Only children older
than 30 months of age were recruited. Children with spontaneous
clearance of HCV were routinely followed up to 18 years of age as
part of the local research protocol.
Patients
One hundred and eighty six consecutive children were
recruited. Nine of them (4.8%) were not enrolled as the parents
did not provide the informed consent. Of the 177 children enrolled
(95.2%), 30 consecutive children (16.9%) spontaneously cleared
the virus and 133 (83.1%) were chronically infected.
Comparison with individuals studied in the 1000
Genomes Project
Allele and genotype frequencies for the rs12979860 SNP were
examined for concordance with the individuals studied in the 1000
Genomes Project (http://www.1000genomes.org), October 2010
release [12].
Laboratory methods
Polymerase chain reaction for HCV was performed as
previously described [15]. HCV antibodies were investigated by
a third generation enzyme-linked immunosorbent assay (ELISA)
(Ortho Diagnostic System Inc., Raritan, NJ) and confirmed by
Western blot analysis (Innogenetics, Zwijndrecht, Belgium). IFNL3
rs12979860 SNP genotyping was performed using Allelic Dis-
crimination assays from Applied Biosystems following the instruc-
tions of the manufacturer. Genotyping was performed using
Taqman custom-designed primers and probes as follows: forward
primer GCCTGTCGTGTACTGAACCA, reverse primer GC-
GCGGAGTGCAATTCAAC, and probes TGGTTCGCGCCT-
TC (VIC) and CTGGTTCACGCCTTC (FAM) (Applied
Biosystems). Before performing the PCR reactions DNA is added
with Allelic Discrimination Assay Mix and TaqMan Universal
PCR Master Mix to MicroAmp Optical 96-Well Reaction Plates
(Applied Biosystems). Real-Time PCR reactions were performed
using the 7500 Fast Real-Time PCR System. After preheating for
10 min. at 92uC, 40 cycles of 15 seconds at 95uC and one minute
at 60uC followed. Data were analyzed using the ABI SDS software
(Applied Biosystems).
Statistical analysis
Data were processed with the SPSSX statistical package (SPSS,
Inc., Chicago, IL). Two tailed P values were used and a p value ,
0.05 was defined as significant. Differences in frequencies were
evaluated by chi2 test or Fisher’s exact probabilities. Odds ratio
(OR) and 90% confidence intervals (CI) were calculated. Age was
presented as median and interquartile range (IQR). Hardy-
Weinberg Equilibrium (HWE) was tested. A deviation from HWE
was defined with a criterion of p value ,0.05.
Results
HCV infected children
Thirty children (16.9%) spontaneously cleared the virus and 133
(83.1%) were chronically infected. The characteristics of the
children enrolled are summarized in table 1.
Data extracted from the 1000 Genomes Project database
Alleles and genotypes frequencies for the rs12979860 SNP were
available in the 1000 Genomes Project database for 1,092
individuals. Rs12979860 alleles and genotypes frequencies ac-
cording to the ethnic origin are summarized in table 2. The
frequencies of the C and T alleles in each population sampled is
described in figure 1. The highest frequencies of the C allele and of
the C/C genotype were found in East Asians (92.5% and 85%,
respectively). Among the 379 individuals of European ancestry, 98
(25.9%) were Italians. Italy was the nation where the present study
was carried out. The frequency of the C allele and of the C/C
genotype were significantly lower in the Italians when compared
with the remaining Europeans (for the C allele: 59.7% and 71.2%,
respectively, p = 0.003; for the C/C genotype: 34.7% and 51.2%,
respectively, p= 0.005).
Comparison of the allele frequencies
In the HCV cohort, the frequency of the C allele was 76.7%
among children who spontaneously cleared the virus versus 56.5%
among children with chronic infection (p = 0.004; OR: 2.5;
90%CI: 1.4–4.6). The frequency of the C allele among children
in the HCV cohort who spontaneously cleared the infection was
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greater than that observed in the individuals of European ancestry
but the difference did not reach the threshold of significance (75%
versus 68.2%, p= 0.2). A significant difference was observed when
the frequencies of C alleles of the children with spontaneous
clearance and of Italians enrolled in the 1000 Genomes Project
database were compared (76.7% versus 59.7%, p= 0.02; OR: 2.2;
90%CI: 1.2–4.1). The T-allele frequency was significantly greater
in the chronically infected cohort compared with the European
controls (43.5% versus 31.8%, p= 0.003).
Comparison of genotype frequencies
Genotypes were in Hardy-Weinberg equilibrium in the cohort
of children with HCV infection (p= 0.63), in individuals of
European ancestry and Italians selected from the 1000 Genomes
Project database (table 2). Children with the C/C genotype were 2
times more likely to clear HCV relative to children with the C/T
and T/T genotype combined (OR: 2.7; 90%CI: 1.3–5.8,
p = 0.02). No difference was observed for clearance of HCV
between the C/T and T/T genotypes and between the C/C and
the C/T. Clearance was more common in children with the C/C
genotype than in those with T/T (OR: 10.3; 90%CI: 1.3–217.8,
p = 0.01). The C/C genotype was found in 56.7% of the children
with spontaneous clearance of HCV and 47% in individuals of
European ancestry (p = 0.7). The C/C genotype was more
common in children with spontaneous clearance of HCV than
in the Italians present in the 1000 Genomes Project database
(56.7% versus 34.7%, p= 0.03; OR 2.5; 90%CI 1.1–5.4).
Table 1. Characteristics of the children enrolled in the
hepatitis C virus cohort.
Spontaneous
clearance Chronic infection
30 (16.9%) 147 (83.1%)
Male/female 17/13 79/68
Age years, median (IQR) 12.7 (6.8) 11 (6.9)
Genotype
1 9 89
2 0 17
3 5 25
4 0 15
multiple genotypes 2 1
not determined 14 0
C allele 46 (76.7%)* 166 (56.5%)*
T allele 14 (23.3%) 128 (43.5%)
C/C genotype 17 (56.7%)** 48 (32.7%)
C/T genotype 12 (40%) 70 (47.6%)
T/T genotype 1 (3.3%)*** 29 (19.7%)
Note: IQR, interquartile range; * p = 0.004; OR 2.5; 90%CI 1.4–4.6; ** C/C
genotype versus C/T and T/T combined p= 0.02; OR = 2.7; 90%CI 1.3–5.8; *** C/
C genotype versus T/T p = 0.01; OR = 10.3; 90%CI 1.3–217.8
doi:10.1371/journal.pone.0085899.t001
Table 2. Rs12979860 alleles and genotypes frequencies in the 1,092 individuals enrolled in the 1000 Genomes Project database.
Population Alleles n (%) Genotypes n (%) HWE
C T C/C C/T T/T n
EUROPEANS 517 (68.2) 241 (31.8) 178 (47) 161 (42.5) 40 (10.5) 0.68 379
Iberians (Spain) 22 (78.6) 6 (21.4) 9 (64.3) 4 (28.6) 1 (7.1) 0.57 14
Utah residents (U.S.A) with Northern and
Western European ancestry
127 (74.7) 43 (25.3) 49 (57.6) 29 (34.2) 7 (8.2) 0.37 85
Finnish 133 (71.5) 53 (28.5) 47 (50.5) 39 (42) 7 (7.5) 0.77 93
British 118 (66.3) 60 (33.7) 39 (43.8) 40 (45) 10 (11.2) 0.95 89
Tuscans (Italy) 117 (59.7)* 79 (40.3) 34 (34.7)** 49 (50) 15 (15.3) 0.69 98
Europeans (without Tuscans) 400 (71.2)* 162 (28.8) 144 (51.2)** 112 (39.9) 25 (8.9%) 0.63 281
EAST ASIANS 529 (92.5) 43 (7.5) 243 (85) 43 (15) – 0.41 286
Japanese (Tokyo) 159 (89.3) 19 (10.7) 70 (78.7) 19 (21.3) – 0.26 89
Chinese (Beijing) 179 (92.3) 15 (7.7) 82 (84.5) 15 (15.5) – 0.41 97
Chinese 191 (95.5) 9 (4.5) 91 (91) 9 (9) – 0.63 100
AFRICANS 195 (39.6) 297 (60.4) 38 (15.4) 119 (48.4) 89 (36.2) 0.86 246
Kenyans 95 (49) 99 (51) 19 (19.6) 57 (58.8) 21 (21.6) 0.08 97
Nigerians 59 (33.5) 117 (66.5) 11 (12.5) 37 (42) 40 (45.5) 0.59 88
Afro-Americans 41 (33.6) 81 (66.4) 8 (13.1) 25 (41) 28 (45.9) 0.52 61
MIXED AMERICANS 202 (55.8) 160 (44.2) 55 (30.4) 92 (50.8) 34 (18.8) 0.68 181
Mexicans 69 (52.3) 63 (47.7) 17 (25.8) 35 (53) 14 (21.2) 0.61 66
Puertoricans 71 (64.5) 39 (35.5) 22 (40) 27 (49.1) 6 (10.9) 0.59 55
Colombians 62 (51.7) 58 (48.3) 16 (26.7) 30 (50) 14 (23.3) 0.99 60
Note: HWE, Hardy-Weinberg Equilibrium. * p = 0.003. ** p = 0.005.
doi:10.1371/journal.pone.0085899.t002
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Discussion
The present study shows that the C allele and the C/C genotype
of the rs12979860 SNP of the IFNL3 gene are associated with
spontaneous resolution of HCV infection in Italian children. The
results of this study were obtained comparing the frequencies of
the C and T allele and of the different genotypes of the
rs12979860 SNP of the IFNL3 gene between a cohort of children
who spontaneously cleared or where chronically infected by HCV
with ethnically matched controls. The rationale for this study was
that, if the polymorphism influences natural clearance also in
children, we would have obtained a frequency difference in these
comparisons, since the children who naturally clear the virus will
be excluded from the chronic infection cohort, thereby reducing
the frequency of the allele that increases the likelihood of
spontaneous clearance. The present results confirm the association
demonstrated in adults [1]. Two preliminary paediatric studies
were already published on the same topic [7,8] that enrolled a
limited number of patients (n = 15 and n=26, respectively) and
used the classical approach of comparing the frequencies of the C/
C genotypes in children with clearance and chronic infection. In
the present study a significantly higher number of children was
enrolled and the value of the results was enforced and validated by
the comparisons of alleles and genotypes frequencies among
children with chronic infection, spontaneous clearance and,
differently by previous studies, with a cohort of ethnically matched
controls.
One of the risks of the interpretation of genome wide association
studies is to find spurious associations [17]. For this reason, the
data extracted by the 1000 Genomes Project in this study were
analyzed for consistency with the previous data published on the
topic [1]. A higher frequency of the C allele was confirmed in East-
Asians, followed by the Europeans and Africans-Americans [1].
The patterns of genetic variation across different populations are
shaped by history, environment, and stochastic processes. It is
noteworthy that, among the Europeans, a group of individuals
from Italy (the country were the study was carried out) had
significantly lower frequencies of the C allele and of the C/C
genotype than the other Europeans. The European individuals
therefore were not considered representative of the cohort of HCV
infected children and Italians were selected as reference. The
rationale for this choice was the observation that different studies
have shown that, despite low average levels of genetic differenti-
ation among Europeans, there is a close correspondence between
genetic and geographic distances [17,18]. Two major axes of
genetic variation have been observed within Europe, namely from
North to South and from East to West and two representative
populations have been identified, the CEU (Northwestern Europe)
and the TSI populations (Tuscan Italians from Southern Europe).
The pattern of variation of the rs12979860 SNP of the IFNL3 gene
observed among different European populations studied in the
1000 Genome Project is in line with the gradient of genetic
variation described among Europeans following the North-
Northwest/South-Southeast geographic axis [17]. When inter-
preting genome wide association studies the optimal solution is to
select the geographically closer population as reference [17,18].
Spurious associations can arise if genetic structure is not properly
accounted for and the results of the present article are the proof of
it.
The present study contributes to the understanding of the
mechanisms of clearance of HCV infection in children with
perinatal infection. Spontaneous clearance of HCV in children
perinatally infected has been associated so far with a transaminase
flare in the first year of life and with HCV genotype 3 infection
[15,19]. IFNL3 is a human gene of the host system of innate
antiviral defense. The outcome of HCV infection is dependent on
the balance between innate immunity of the host and the multiple
mechanisms to regulate and evade innate immunity evolved by
HCV. Although early studies failed to find altered mRNA
expression of IFNL3 associated with different IFNL3 genotypes,
since the specificity of real-time PCR primers for IFNL3 has
increased (to differentiate between IFN-l3 and the closely related
IFN-l2), it is now clear that SNPs of the IFNL3 gene affect the
expression of IFN-l3 with the unfavourable allele resulting in less
IFN-l3 expression [20]. Furthermore, recently, a study showed
that adults with the unfavourable IFNL3 genotype have depressed
innate immune function, particularly with respect to NK cells,
suggesting that the decreased expression of IFNL3 affects innate
immunity and therefore clearance of HCV [21]. Quantitative and
qualitative differences exist between adult and neonatal innate
Figure 1. Frequency of rs12979860 C and T alleles in the diverse ethnic groups present in the 1000 Genomes Project database.
doi:10.1371/journal.pone.0085899.g001
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immune cells. Neonatal innate immune cells, for example, as
compared with those of adults, have been described to produce
lower levels of IFNs [22]. The activity of NK cells also differs
between neonates and adults with many differences demonstrated
in the pattern of cell-surface activating and inhibitory receptors
[22]. Newborn and infant’s immune responses are oriented
towards immunological tolerance and neonatal innate immune
defences are skewed towards protection against extracellular
bacterial pathogens rather than intracellular bacterial pathogens
and viruses [11]. Despite innate immunity in neonates and infants
can be condidered physiologically depressed, it was of interest to
evaluate if it still plays a role, in children as in adults, in
spontaneous elimination of the virus. The results of the present
study, confirming that the rs12979860 SNPs influences the natural
history of hepatitis C virus in children, support that hypothesis.
SNPs of the IFNL3 gene have been associated in adults with
both spontaneous clearance of HCV infection and response to
treatment with combined dual therapy with pegylated IFN and
ribavirin. These results suggest that IFN-l3 has a key role in
determining both treatment-induced and spontaneous clearance of
HCV. The association between rs12979860 SNP of the IFNL3
gene and spontaneous clearance in children and the homology of
this result with those obtained in adults, supports the hypothesis
that IFNL3 gene polymorphisms should be evaluated extensively as
pretreatment predictor of virological response also in children.
In conclusion, the present result demonstrates that the
frequencies of the C allele and the C/C genotype of the
rs12979860 SNP of the IFNL3 gene are higher in a cohort of
children who spontaneously cleared HCV infection when com-
pared to children with chronic hepatitis C and ethnically matched
controls. The rs12979860 SNP of the IFNL3 gene influences
spontaneous resolution of HCV infection in Italian children.
Acknowledgments
We are grateful to the parents and to all the children enrolled in the present
study. We are thankful to Dr Davide Mei for his precious scientific advice
and technical assistance. This study has been carried out in the context of
the ‘‘Progetto Giovani Ricercatori’’ of the Meyer Children’s University
Hospital.
Author Contributions
Conceived and designed the experiments: GI PLC GB PAT MdM CA
MR. Performed the experiments: GM MM EB CA. Analyzed the data: GI
GN PLC PAT EB CA MdM MR. Contributed reagents/materials/
analysis tools: GM MM EB CA. Wrote the paper: GI MdM CA MR.
References
1. Thomas DL, Thio CL, Martin MP, Qi Y, Ge D, et al. (2009) Genetic variation
in IL28B and spontaneous clearance of hepatitis C virus. Nature 461: 798–801.
2. Ge D, Fellay J, Thompson AJ, Simon JS, Shianna KV, et al. (2009). Genetic
variation in IL28B predicts hepatitis C treatment-induced viral clearance.
Nature 461: 399–401.
3. Urban T, Charlton MR, Goldstein DB (2012) Introduction to the genetics and
biology of interleukin-28B. Hepatology 56: 361–366.
4. Yan KK, Guirgis M, Dinh T, George J, Dev A, et al. (2008) Treatment
responses in Asians and Caucasians with chronic hepatitis C infection.
World J Gastroenterol 14: 3416–3420.
5. Muir AJ, Bornstein JD, Killenberg PG; Atlantic Coast Hepatitis Treatment
Group (2004) Peginterferon alfa-2b and ribavirin for the treatment of chronic
hepatitis C in blacks and non-Hispanic whites. N Engl J Med 350: 2265–2271.
6. Liu CH, Liu CJ, Lin CL, Liang CC, Hsu SJ, et al. (2008) Pegylated interferon-
alpha-2a plus ribavirin for treatment-naive Asian patients with hepatitis C virus
genotype 1 infection: a multicenter, randomized controlled trial. Clin Infect Dis
47: 1260–1269.
7. Ruiz-Extremera A, Mun˜oz-Ga´mez JA, Salmero´n-Ruiz MA, de Rueda PM,
Quiles-Pe´rez R, et al. (2011) Genetic variation in interleukin 28B with respect to
vertical transmission of hepatitis C virus and spontaneous clearance in HCV-
infected children. Hepatology 53: 1830–1838.
8. Indolfi G, Sambrotta M, Moriondo M, Azzari C, Resti M (2011) Genetic
variation in interleukin-28B locus is associated with spontaneous clearance of
HCV in children with non-1 viral genotype infection. Hepatology 54: 1490–
1491.
9. Bortolotti F, Verucchi G, Camma` C, Cabibbo G, Zancan L, et al. (2008) Long-
term course of chronic hepatitis C in children: from viral clearance to end-stage
liver disease. Gastroenterology 134: 1900–1907.
10. Afdhal NH (2004) The natural history of hepatitis C. Semin Liver Dis 24: 3–8.
11. Prendergast AJ, Klenerman P, Goulder PJ (2012) The impact of differential
antiviral immunity in children and adults. Nat Rev Immunol 12: 636–648.
12. Genomes Project Consortium, Abecasis GR, Altshuler D, Auton A, Brooks LD,
Durbin RM, et al. (2010) A map of human genome variation from population-
scale sequencing. Nature 467: 1061–1073.
13. Indolfi G, Azzari C, Resti M (2013) Perinatal Transmission of Hepatitis C Virus.
J Pediatr 163: 1549–1552.
14. Indolfi G, Resti M (2009) Perinatal transmission of hepatitis C virus infection.
J Med Virol 81: 836–843.
15. Resti M, Jara P, Hierro L, Azzari C, Giacchino R, et al. (2003) Clinical features
and progression of perinatally acquired hepatitis C virus infection. J Med Virol
70:373–377.
16. Indolfi G, Azzari C, Moriondo M, Lippi F, de Martino M, et al. (2006) Alanine
transaminase levels in the year before pregnancy predict the risk of hepatitis C
virus vertical transmission. J Med Virol 78: 911–914.
17. Novembre J, Johnson T, Bryc K, Kutalik Z, Boyko AR, et al. (2008) Genes
mirror geography within Europe. Nature 456: 98–101.
18. Stathias V, Sotiris GR, Karagiannidis I, Bourikas G, Martinis G, et al. (2012)
Exploring genomic structure differences and similarities between the Greek and
European HapMap populations: implications for association studies. Ann Hum
Genet 76: 472–483.
19. European Paediatric Hepatitis C Virus Network. (2005) Three broad modalities
in the natural history of vertically acquired hepatitis C virus infection. Clin Infect
Dis 41: 45–51.
20. Langhans B, Kupfer B, Braunschweiger I, Arndt S, Schulte W, et al. (2011)
Interferon-lambda serum levels in hepatitis C. J Hepatol 54: 859–865.
21. Naggie S, Osinusi A, Katsounas A, Lempicki R, Herrmann E, et al. (2012)
Dysregulation of innate immunity in hepatitis C virus genotype 1 IL28B-
unfavorable genotype patients: impaired viral kinetics and therapeutic response.
Hepatology 56: 444–454.
22. Kollmann TR, Crabtree J, Rein-Weston A, Blimkie D, Thommai F, et al. (2009)
Neonatal innate TLR-mediated responses are distinct from those of adults.
J Immunol 183: 7150–7160.
IFNL3 Gene and Hepatitis C in Children
PLOS ONE | www.plosone.org 5 January 2014 | Volume 9 | Issue 1 | e85899
